Anne Samuel
Stock Analyst at JP Morgan
(3.53)
# 758
Out of 4,827 analysts
64
Total ratings
58.54%
Success rate
2.34%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $25.39 | +41.79% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $239.53 | +3.95% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $10.78 | +11.32% | 12 | Mar 10, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $240 → $232 | $153.45 | +51.19% | 6 | Feb 18, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $23.37 | -1.58% | 7 | Jan 28, 2025 | |
| DOCS Doximity | Maintains: Neutral | $30 → $48 | $59.35 | -19.12% | 5 | Nov 21, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $25.38 | +10.32% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $23.30 | -18.45% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $22.38 | -6.17% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $4.18 | +211.00% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $40.49 | -33.32% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.81 | +77.94% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $91.33 | +18.25% | 8 | Apr 2, 2024 |
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $25.39
Upside: +41.79%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $239.53
Upside: +3.95%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $10.78
Upside: +11.32%
IQVIA Holdings
Feb 18, 2025
Maintains: Overweight
Price Target: $240 → $232
Current: $153.45
Upside: +51.19%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $23.37
Upside: -1.58%
Doximity
Nov 21, 2024
Maintains: Neutral
Price Target: $30 → $48
Current: $59.35
Upside: -19.12%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $25.38
Upside: +10.32%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $23.30
Upside: -18.45%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $22.38
Upside: -6.17%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $4.18
Upside: +211.00%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $40.49
Upside: -33.32%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.81
Upside: +77.94%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $91.33
Upside: +18.25%